A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
In early November 2019, the U.S. Food and Drug Administration (FDA) updated a previous safety communication about the potential of biotin to significantly interfere with diagnostic tests. The update reiterates the warning
From - Diagnostic Testing & Emerging Technologies
The notion of empowering patients to take control over their own health care is particularly powerful within the realm of…
By Robert Liles bio
Over the last year, a number of genetic testing fraud investigations and prosecutions have been initiated by…